文献精粹当前位置:首页炎症管理 > 文献精粹 >

Therapeutic effects of Stronger Neo-Minophagen C (SNMC) in patients with chronic

来源:Hepatology Research 提供者:卫材医学市场部 时间:2009-07-30 点击:
  To evaluate the therapeutic efficacy of Stronger Neo-Minophagen C (SNMC) in patientswith chronic liver diseases, a multicenter prospective study was performed in Beijing, China.A total of 109 patients were treated with SNMC intravenous injection and SNMC tablets (Minophagen Pharmaceutical Co., Tokyo, Japan). They responded to the treatment with marked effective rate of 66% and overall effective rate of 75%. SNMC was shown to lower serum ALT and AST levels shortly after the administration, especially for the patients with higher serum levels. Serum bilirubin was reduced simultaneously, and metabolism of protein was improved. SNMC was proved to be safe with minimal side effects.